A detailed history of Moisand Fitzgerald Tamayo, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Moisand Fitzgerald Tamayo, LLC holds 84 shares of EXAS stock, worth $5,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Holding current value
$5,334
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$40.91 - $56.0 $3,436 - $4,704
84 New
84 $4,000
Q2 2022

Aug 01, 2022

SELL
$35.61 - $76.23 $142 - $304
-4 Reduced 57.14%
3 $0
Q1 2022

Apr 29, 2022

BUY
$57.56 - $82.54 $402 - $577
7 New
7 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Moisand Fitzgerald Tamayo, LLC Portfolio

Follow Moisand Fitzgerald Tamayo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.